Israeli student develops drug-delivering skin gel; Nanorobots offer delivery at the atomic level;

> A student at the Hebrew University of Jerusalem has developed a gel made of lyotropic liquid crystals for the application of drugs directly to the skin where oral drugs can cause severe side effects. Marganit Cohen-Avrahami won one of this year's Kaye Innovation Awards for her work. Report

> Scientific American, in its "30 Under 30" report highlighting young scientists, interviewed Aniket Magarkar, who studies liposomes that could help develop nanorobots capable of delivering drugs. Report

> Alchemy Pharmatech snagged a £400,000 investment from the North West Fund for its intranasal drug-delivery system for DNA vaccines, hormone replacement compounds and pain-control products. Release

> Access Pharmaceuticals ($ACCP) signed a licensing agreement with AMAG Pharmaceuticals ($AMAG) for $3.3 million to market its MuGard, a mucoadhesive treatment for oral wounds. Release

> Discovery Labs ($DSCO) presented an analysis that showed its Surfaxin treatment for infant respiratory distress syndrome, the first synthetic, peptide-containing surfactant approved by the FDA, could save up to $562,000 per 100 patients. Release

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.